๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

New formulation intravenous melphalan in the treatment of patients with metastitic renal cancer

โœ Scribed by Carla I. Falkson

Publisher
Springer US
Year
1993
Tongue
English
Weight
84 KB
Volume
11
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Renal clearance and protein binding of m
Renal clearance and protein binding of melphalan in patients with cancer
โœ Phillip A. Reece; Heather S. Hill; R. Malcolm Green; Raymond G. Morris; Barry M. ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Springer ๐ŸŒ English โš– 426 KB

The renal clearance of melphalan and the fraction unbound in plasma were determined after intravenous infusion of 5 mg/m2 over 5 min in nine patients with cancer to obtain information regarding the mechanism of renal handling of melphalan. Four of the patients underwent bone marrow transplantation a

Renal function in the elimination of ora
Renal function in the elimination of oral melphalan in patients with multiple myeloma
โœ C. G. Adair; J. M. Bridges; Z. R. Desai ๐Ÿ“‚ Article ๐Ÿ“… 1986 ๐Ÿ› Springer ๐ŸŒ English โš– 329 KB

Pharmacokinetic studies in 11 patients with multiple myeloma were undertaken on the first and last days of one course of chemotherapy. The drug was administered PO in single doses of 6-14 mg daily. Melphalan concentrations were determined by high-performance liquid chromatography. The interpatient v

A new sublingual formulation of apomorph
A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease
โœ Dr. T. van Laar; C. Neef; M. Danhof; K. I. Roon; R. A. C. Roos ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 503 KB

## Abstract A new formulation of a sublingual tablet with 10 mg apomorphine was examined in 13 patients with Parkinson's disease. Vitamin C (250 mg) was added sublingually to lower the salivary pH. Four patients received sublingual apomorphine and nine received sublingual apomorphine as well as vit